Lifeward Ltd. Reports Q1 2025 Financial Results

Rewalk Robotics Ltd. ( (LFWD) ) has released its Q1 earnings. Here is a breakdown of the information Rewalk Robotics Ltd. presented to its investors.

Lifeward Ltd. is a global leader in innovative medical technology, focusing on solutions that transform the lives of individuals with physical limitations or disabilities, with operations spanning the United States, Israel, and Germany. In its first quarter of 2025 financial results, Lifeward Ltd. reported a revenue of $5.0 million, a slight decline from the previous year, alongside a notable improvement in gross margin and a reduction in operating expenses. Key highlights include the launch of the ReWalk 7 exoskeleton in the U.S. market, securing a significant insurance claim approval, and expanding partnerships to enhance market penetration. Despite a net loss of $4.8 million, the company showed progress with a reduced operating loss compared to the previous year and maintained a strong cash position with $5.7 million in cash and no debt. Looking forward, Lifeward Ltd. remains optimistic about its growth prospects, with expectations of full-year revenue between $28 million and $30 million, driven by strategic partnerships and product innovations.